The revenue stands at ₹7,474.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.29 per cent from ₹7,167.52 crore. This corresponds to a year-on-year *(YoY) growth of 31.89 per cent.
Operating Profit stands at ₹2,354.24 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.28 per cent from ₹1,835.28 crore. This corresponds to a year-on-year *(YoY) growth of 78.19 per cent.
PBDT stands at ₹2,374.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.42 per cent from ₹1,835.00 crore. This corresponds to a year-on-year *(YoY) growth of 84.23 per cent.
Profit Before Tax stands at ₹1,928.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 26.67 per cent from ₹1,522.04 crore. This corresponds to a year-on-year *(YoY) growth of 115.22 per cent.
Net Profit stands at ₹1,468.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.41 per cent from ₹1,180.51 crore. This represents a 87.72 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Lupin | 3.43% | 2.31% | 9.92% | 7.82% | 11.86% | 25.22% |
| Cipla | 0.15% | -0.46% | 5.06% | 21.31% | -0.60% | -3.47% |
| Dr Reddy's Labs | 2.54% | 1.30% | 7.74% | 14.90% | 10.62% | 4.92% |
| Zydus Lifesci. | 3.54% | 2.59% | 4.92% | 30.60% | 23.06% | 14.23% |
| Mankind Pharma | 2.06% | -0.60% | 7.32% | 24.05% | 9.50% | 4.88% |
| Aurobindo Pharma | 3.85% | 2.81% | 11.59% | 21.85% | 31.15% | 36.78% |
| Laurus Labs | 1.09% | 1.58% | 9.77% | 45.94% | 36.60% | 98.50% |
Chairman (Non-Executive) : M D Gupta
Managing Director : Nilesh Deshbandhu Gupta.
Director & Chief Executive Officer : Vinita Gupta
Company Sec. & Compli. Officer : R V Satam
Independent Director : Jean-Luc Belingard
Director & Group CFO : Ramesh Swaminathan
Independent Director : Mark D McDade
Independent Director : K B S Anand
Independent Director : Jeffrey Kindler
Independent Director : Alfonso Zulueta
Independent Director : Punita Lal